of data
support
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
357-09-5Fludrocortisone Acetate Impurity 1
● In Stock
| Catalogue No.: | VE0023044 |
|---|---|
| CAS No.: | 357-09-5 |
| Mol. Formula: | C19H25FO3 |
| Mol. Weight: | 320.4 g/mol |
Additional information on CAS 357-09-5
Parent drug
FludrocortisoneIUPAC Name
(8S, 9R, 10S, 11S, 13S, 14S)-9-Fluoro-11-hydroxy-10, 13-dimethyl-1, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16-dodecahydro-3H-cyclopenta[a]phenanthrene-3, 17(2H)-dionePharmacopoeial Synonyms
N/AOther Synonyms
Fluorohydroxyandrostenedione; 9-fluoro-11-beta-hydroxy-androst-4-ene-3, 17-dione; Androst-4-ene-3, 17-dione, 9-fluoro-11-hydroxy-, (11-beta)-(9CI)Smiles
O=C(C=C1CC[C@@]2([H])[C@]3([H])CC4)CC[C@]1(C)[C@@]2(F)[C@@H](O)C[C@]3(C)C4=OInChI
InChI=1S/C19H25FO3/c1-17-10-16(23)19(20)14(13(17)5-6-15(17)22)4-3-11-9-12(21)7-8-18(11, 19)2/h9, 13-14, 16, 23H, 3-8, 10H2, 1-2H3/t13-, 14-, 16-, 17-, 18-, 19-/m0/s1Description
Fludrocortisone Acetate Impurity 1 is a meticulously characterized reference material that complies with rigorous regulatory requirements | including those defined by USP | EMA | JP | and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial manufacturing of Fludrocortisone. It is further supported by a detailed Structure Elucidation Report (SER) | ensuring high accuracy and reliability across a broad range of analytical applications.
Request a Quote
"*" indicates required fields
Other products related to Fludrocortisone impurities
Fludrocortisone Acetate / Fludrocortisone
